This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Title: Yasuo Fujimoto: Innovator in Human Adrenergic Receptor Research
Introduction
Yasuo Fujimoto is a notable inventor based in Japan, recognized for his contributions to the field of pharmacology. His work primarily focuses on the development of ligands for human adrenergic receptors, which play a crucial role in various physiological processes.
Latest Patents
Fujimoto's most significant patent is titled "Human .beta.3 Adrenergic Receptor Ligand, And Food Or Pharmaceutical Product Containing The Same." This invention involves a human adrenergic .beta.3 receptor ligand that comprises three components: (A) an unsaturated fatty acid with at least three double bonds or a pharmaceutically acceptable salt thereof; (B) an unsaturated fatty acid with one or two double bonds or a pharmaceutically acceptable salt thereof; and (C) a saturated fatty acid or a pharmaceutically acceptable salt thereof. The patent emphasizes the potential of this ligand in food products and pharmaceuticals, particularly as an agent for the prevention and treatment of lifestyle-related diseases such as obesity, diabetes, hyperlipidemia, hypertension, and gout.
Career Highlights
Fujimoto is currently associated with Ricom Corporation, where he continues to advance his research in the field of adrenergic receptors. His innovative approach has garnered attention in the scientific community, despite having no patents attributed to him at this time.
Collaborations
Fujimoto has collaborated with esteemed colleagues, including Shoichi Kurihara and Tadao Hamaya, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yasuo Fujimoto's work in the development of human adrenergic receptor ligands represents a significant advancement in pharmacological research. His contributions have the potential to impact the treatment of various lifestyle-related diseases, showcasing the importance of innovation in the field of health and medicine.